ArticleMolecular cancer therapeutics2023

A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies.

Sabine Zitzmann-Kolbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.